PARIS, FRANCE, 22 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today it has completed the acquisition of Memo Therapeutics AG, a ...
The kidney is now the highest on the "wanted list" of organs, with 10,000 renal failure patients waiting for transplants.
Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically meaningful improvements of protein in urine observed as early as two weeks, with s ...
Dimerix Limited (ASX: DXB, "Dimerix") a clinical-stage biopharmaceutical company developing kidney disease treatments, is pleased to announce that it has acquired DMX-652 for all indications from ...
Each week, photographer Ruth Medjber asks one person to share a tale from their own life. This week, she meets kidney ...
ROBINSON, Texas (KWTX) — Brandon Crouch was running out of time. The 54-year-old Robinson, Texas, man and owner of Ironhorse Roofing had been on dialysis for nearly three and a half years after Type 1 ...
Fabhalta slowed eGFR decline by 48% vs placebo over two years, demonstrating kidney function preservation1 Clinically ...
Industry-wide coverage policy expands reimbursement framework for donor-derived cell-free DNA testingSupports iMDx's ...
Tormented by transience, Caitlin McDonald's life was as fragile and fleeting as the butterflies she saved from the street.
(Nasdaq: CDNA), a leading precision medicine diagnostics company in transplant, specialty oncology, and cell therapy, today announced the finalization of the Medicare Local Coverage Determination (LCD ...
Asianet Newsable on MSN
Kota: Women refuse dialysis, demand kidney transplants after 5 deaths
Following the deaths of five women, female patients at Kota Medical College are refusing dialysis. They demand kidney ...
For people waiting on a kidney transplant, the hardest part is often finding the right donor, but for Sean and Chris Cullinan — they’re the perfect match. 10TV caught up with the brothers, who are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results